Hanson Curtis A, Weinhold Paul S, Afshari Hessam M, Dahners Laurence E
Departmernt of Orthopaedic Surgery, Bioinformatics Building, CB #7055, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7055, USA.
Am J Sports Med. 2005 May;33(5):674-9. doi: 10.1177/0363546504269722. Epub 2005 Feb 16.
Studies have suggested that some nonselective nonsteroidal anti-inflammatory drugs, including piroxicam, may improve ligament healing, whereas other nonsteroidal anti-inflammatory drugs, including ibuprofen and the cyclooxygenase-2 inhibitor celecoxib, may have no effect on the mechanical properties or may even deter the healing process. These results might reflect variations in cyclooxygenase enzyme selectivity by different drugs or, alternatively, may be related to their analgesic properties because it is generally accepted that early activity improves ligament healing.
Nonselective nonsteroidal anti-inflammatory drugs improve ligament healing, whereas other analgesics provide lesser degrees of improvement, and cyclooxygenase-2 inhibitors are detrimental.
Controlled laboratory study.
One hundred fifty-five Sprague-Dawley rats were divided into 7 treatment groups (piroxicam, naproxen, rofecoxib, butorphanol, 2 doses of acetaminophen, and control). The right medial collateral ligament of each rat was transected, and the drugs were administered postoperatively on days 1 to 6. On day 14, the rats were sacrificed, and mechanical testing was performed on the medial collateral ligament.
The piroxicam group demonstrated significantly greater load to failure (27%) compared with the control. No significant differences were observed between other groups.
Piroxicam improves ligament healing, but this effect cannot be attributed to all nonselective nonsteroidal anti-inflammatory drugs. Opiate analgesics, acetaminophen, and cyclooxygenase-2 inhibitors do not appear to categorically affect ligament healing.
In the treatment of ligament injury, piroxicam may be a drug of choice.
研究表明,包括吡罗昔康在内的一些非选择性非甾体抗炎药可能会促进韧带愈合,而包括布洛芬和环氧化酶 -2 抑制剂塞来昔布在内的其他非甾体抗炎药可能对力学性能没有影响,甚至可能阻碍愈合过程。这些结果可能反映了不同药物对环氧化酶的选择性差异,或者,也可能与它们的镇痛特性有关,因为人们普遍认为早期活动可促进韧带愈合。
非选择性非甾体抗炎药可促进韧带愈合,而其他镇痛药的促进程度较小,且环氧化酶 -2 抑制剂有不利影响。
对照实验室研究。
155 只 Sprague-Dawley 大鼠被分为 7 个治疗组(吡罗昔康、萘普生、罗非昔布、布托啡诺、2 种剂量的对乙酰氨基酚和对照组)。每只大鼠的右内侧副韧带被切断,术后第 1 至 6 天给予药物。在第 14 天,处死大鼠,并对内侧副韧带进行力学测试。
与对照组相比,吡罗昔康组的破坏载荷显著更高(27%)。其他组之间未观察到显著差异。
吡罗昔康可促进韧带愈合,但这种作用不能归因于所有非选择性非甾体抗炎药。阿片类镇痛药、对乙酰氨基酚和环氧化酶 -2 抑制剂似乎不会绝对影响韧带愈合。
在韧带损伤的治疗中,吡罗昔康可能是一种选择药物。